Corrado Tarella

10.3k total citations · 1 hit paper
213 papers, 6.2k citations indexed

About

Corrado Tarella is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Corrado Tarella has authored 213 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pathology and Forensic Medicine, 86 papers in Oncology and 71 papers in Hematology. Recurrent topics in Corrado Tarella's work include Lymphoma Diagnosis and Treatment (110 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Hematopoietic Stem Cell Transplantation (37 papers). Corrado Tarella is often cited by papers focused on Lymphoma Diagnosis and Treatment (110 papers), Chronic Lymphocytic Leukemia Research (42 papers) and Hematopoietic Stem Cell Transplantation (37 papers). Corrado Tarella collaborates with scholars based in Italy, United States and Egypt. Corrado Tarella's co-authors include Alessandro Pileri, Marco Bregni, Paolo Corradini, Salvatore Siena, Gianni Bonadonna, Alessandro M. Gianni, Marco Ladetto, Mario Boccadoro, Daniele Caracciolo and Dario Ferrero and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Corrado Tarella

201 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

1989 588 citations Marco Bregni, Salvatore Siena et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Corrado Tarella	2.8k	2.8k	2.5k	1.5k	1.3k	213	6.2k
Ivana N. Micallef	3.2k 1.1×	3.3k 1.2×	2.9k 1.2×	1.7k 1.2×	1.6k 1.3×	256	7.4k
Marine Diviné	2.2k 0.8×	2.8k 1.0×	1.8k 0.7×	1.3k 0.8×	1.1k 0.9×	112	5.1k
Michinori Ogura	3.0k 1.1×	3.2k 1.2×	1.5k 0.6×	1.8k 1.2×	2.2k 1.7×	223	7.3k
Lisa M. Rimsza	2.6k 0.9×	3.5k 1.3×	1.2k 0.5×	1.6k 1.0×	1.2k 1.0×	199	6.2k
Pei Lin	1.8k 0.6×	2.2k 0.8×	2.0k 0.8×	1.9k 1.3×	842 0.7×	224	5.4k
Craig B. Reeder	2.3k 0.8×	2.3k 0.8×	2.5k 1.0×	2.1k 1.4×	628 0.5×	142	5.8k
Thierry Lamy	2.3k 0.8×	2.6k 0.9×	1.9k 0.8×	2.1k 1.4×	2.6k 2.1×	177	6.4k
Chor Sang Chim	2.5k 0.9×	2.1k 0.8×	2.3k 0.9×	866 0.6×	1.1k 0.8×	240	6.8k
Lorenz Trümper	3.3k 1.2×	3.9k 1.4×	1.0k 0.4×	2.1k 1.4×	1.6k 1.3×	203	7.5k
Réda Bouabdallah	2.0k 0.7×	1.9k 0.7×	1.5k 0.6×	913 0.6×	577 0.5×	101	4.0k

Countries citing papers authored by Corrado Tarella

Since Specialization

Citations

This map shows the geographic impact of Corrado Tarella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corrado Tarella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corrado Tarella more than expected).

Fields of papers citing papers by Corrado Tarella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corrado Tarella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corrado Tarella. The network helps show where Corrado Tarella may publish in the future.

Co-authorship network of co-authors of Corrado Tarella

This figure shows the co-authorship network connecting the top 25 collaborators of Corrado Tarella. A scholar is included among the top collaborators of Corrado Tarella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corrado Tarella. Corrado Tarella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabanelli, Valentina, Maria Rosaria Sapienza, Federica Melle, et al.. (2025). Immune Signatures Identify Patient Subsets Deriving Long‐Term Benefit From First‐Line Rituximab in Follicular Lymphoma. eJHaem. 6(1). e1103–e1103. 1 indexed citations

Viviani, Simonetta, Chiara Pavoni, Sally F. Barrington, et al.. (2025). Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. Blood Cancer Journal. 15(1). 165–165.

Mella, Alberto, Valeria Deiana, Ester Gallo, et al.. (2025). Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes. Frontiers in Immunology. 16. 1629521–1629521. 1 indexed citations

Travaini, Laura Lavinia, Francesca Botta, Enrico Derenzini, et al.. (2023). [ ¹⁸ F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphoma. Hematological Oncology. 41(4). 674–682. 4 indexed citations

Domingo‐Doménech, Eva, Manuel Gotti, Alessandro Rambaldi, et al.. (2023). THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INADEQUATE RESPONSE TO CHEMOTHERAPY. THE PRELIMINARY EXPERIENCE FROM THE RAFTING TRIAL. Hematological Oncology. 41(S2). 674–675.

Salamone, Paolina, Giuseppe Fuda, Federico Casale, et al.. (2020). G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial). BMJ Open. 10(3). e034049–e034049. 10 indexed citations

Albano, Domenico, Alberto Bruno, Caterina Patti, et al.. (2019). Whole‐body magnetic resonance imaging (WB‐MRI) in lymphoma: State of the art. Hematological Oncology. 38(1). 12–21. 19 indexed citations

Guidetti, Anna, Carmelo Carlo‐Stella, Silvia L. Locatelli, et al.. (2012). Phase II study of sorafenib in patients with relapsed or refractory lymphoma. British Journal of Haematology. 158(1). 108–119. 38 indexed citations

Buttiglieri, Stefano, Marco Ruella, Alessandra Risso, et al.. (2011). The aging effect of chemotherapy on cultured human mesenchymal stem cells. Experimental Hematology. 39(12). 1171–1181. 57 indexed citations

10.

Filippi, Andrea Riccardo, Pierfrancesco Franco, Carlo Marinone, Corrado Tarella, & Umberto Ricardi. (2007). Treatment options in skeletal localizations of hairy cell leukemia: A systematic review on the role of radiation therapy. American Journal of Hematology. 82(11). 1017–1021. 7 indexed citations

11.

Ladetto, Marco, Barbara Mantoan, Irene Ricca, et al.. (2003). Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. Experimental Hematology. 31(9). 784–788. 9 indexed citations

12.

Cortelazzo, Sergio, Alessandro Rambaldi, Andrea Rossi, et al.. (2001). Intensification of salvage treatment with high‐dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non‐Hodgkin's lymphoma. British Journal of Haematology. 114(2). 333–341. 29 indexed citations

13.

Corradini, Paolo, Corrado Tarella, Marco Bregni, et al.. (2000). Allografting for patients with advanced hematological malignancies: non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with hsv thymidine kinase gene. Blood. 96. 1 indexed citations

14.

Corradini, Paolo, Marco Ladetto, Monica Astolfi, et al.. (1996). Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle‐cell lymphoma. British Journal of Haematology. 94(2). 376–378. 23 indexed citations

15.

Tarella, Corrado, Giovanni Benedetti, Daniele Caracciolo, et al.. (1995). Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high‐dose chemotherapy + G‐CSF. British Journal of Haematology. 91(3). 535–543. 19 indexed citations

16.

Bazzan, M., et al.. (1993). Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration.. PubMed. 78(2). 105–10. 3 indexed citations

17.

Gianni, A. M., et al.. (1991). IMPIEGO CLINICO DEI FATTORI DI CRESCITA EMOPOIETICI. Haematologica. 76. 3–10. 1 indexed citations

18.

Fabritiis, Paolo de, Dario Ferrero, Corrado Tarella, et al.. (1989). Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.. Leukemia Research. 669–674. 6 indexed citations

19.

Am, Gianni, Salvatore Siena, Marco Bregni, et al.. (1989). Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoietic stem cells for autransplantation.. The Lancet. 580–585. 31 indexed citations

20.

Neri, Antonino, James P. Murphy, Lilla Cro, et al.. (1989). Ras oncogene mutation in multiple myeloma.. The Journal of Experimental Medicine. 170(5). 1715–1725. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact